$92.10

-1.07 (-1.15%)

Weekly Expected Move ±4.7%

$78 $82 $86 $90 $95

NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Buy · Power 67 · $1.2B mcap · 8M float · 1.18% daily turnover · Short 59% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE

67.0 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: 50.3% · 5Y Avg: 56.4%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. IRMD has a Narrow competitive edge (67.0/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Cost Advantage. ROIC of 50.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

Low

$106

Avg Target

$106

High

Based on 5 analyst ratings (12 mo)

Analyst Recommendations

Strong Buy: 0Buy: 2Hold: 0Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$105.60

Analysts5

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-02-11	Lake Street	—	$100	$120	+20	+13.2%	$106.02
2026-02-10	Roth Capital	—	$98	$120	+22	+14.1%	$105.15
2025-11-03	Roth Capital	Kyle Bauser	$90	$98	+8	+16.5%	$84.11
2025-11-03	Lake Street	—	Initiated	$100	—	+18.9%	$84.11
2025-10-31	Roth Capital	Kyle Bauser	$60	$90	+30	+17.8%	$76.42
2024-08-02	Roth Capital	Jason Wittes	Initiated	$60	—	+30.0%	$46.15
2024-06-17	Loop Capital Markets	Frank Takkinen	Initiated	$60	—	+38.6%	$43.28

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

May 22, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IRMD receives an overall rating of B. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (1/5).

Rating Change History

Date	From	To
2026-02-19	C-	B
2026-02-11	B	C-
2026-01-14	B+	B
2026-01-03	B	B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 80 Grade A+

Profitability

100

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. IRMD scores highest in Safety (100/100) and lowest in Value (36/100). An overall grade of A+ places IRMD among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

55.78

Safe Zone

Piotroski F-Score

6/9

✓ ✓ ✓ ✓ ✗ ✗ ✗ ✓ ✓

Beneish M-Score

-2.59

Unlikely Manipulator

Ohlson O-Score

-13.29

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

Score: 89.0/100

Trend: Deteriorating

Earnings Quality

75/100

OCF/NI: 1.23x

Accruals: -5.2%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IRMD scores 55.78, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IRMD scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. IRMD's score of -2.59 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IRMD's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IRMD receives an estimated rating of AA (score: 89.0/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). IRMD's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

49.86x

PEG

2.70x

P/S

13.64x

P/B

11.95x

P/FCF

51.41x

P/OCF

42.80x

EV/EBITDA

38.88x

EV/Revenue

13.77x

EV/EBIT

41.02x

EV/FCF

49.29x

Earnings Yield

1.91%

FCF Yield

1.95%

Shareholder Yield

1.25%

Graham Number

$17.42

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 49.9x earnings, IRMD is priced for high growth expectations. Graham's intrinsic value formula yields $17.42 per share, 429% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.782

NI / EBT

Interest Burden

1.042

EBT / EBIT

EBIT Margin

0.336

EBIT / Rev

Asset Turnover

0.833

Rev / Assets

Equity Multiplier

1.141

Assets / Equity

ROE

26.0%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IRMD's ROE of 26.0% is driven by Asset Turnover (0.833), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate

19.18%

Fair P/E

46.87x

Intrinsic Value

$85.98

Price/Value

1.12x

Margin of Safety

-11.96%

Premium

11.96%

Assessment

Overvalued

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with IRMD's realized 19.2% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. IRMD trades at a 12% premium to its adjusted intrinsic value of $85.98, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 46.9x compares to the current market P/E of 49.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$92.10

Median 1Y

$99.18

5th Pctile

$48.39

95th Pctile

$203.57

Ann. Volatility

45.8%

25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Roger Susi President and Chief Executive Officer	$385,598	$—	$780,598
John Glenn Financial ancial Officer	$378,933	$—	$609,994
Jeffrey Chiprin Commercial ercial Officer	$205,000	$—	$529,360

CEO Pay Ratio

4:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $780,598

Avg Employee Cost (SGA/emp): $212,060

Employees: 166

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

166

+3.8% YoY

Revenue / Employee

$504,904

Rev: $83,814,000

Profit / Employee

$135,422

NI: $22,480,000

SGA / Employee

$212,060

Avg labor cost proxy

R&D / Employee

$17,922

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
ROE	7.8%	10.4%	14.0%	15.6%	18.3%	19.5%	17.6%	18.9%	20.1%	22.4%	23.7%	24.7%	25.7%	25.7%	24.3%	25.0%	26.1%	26.8%	24.8%	26.0%	26.03%
ROA	6.6%	8.8%	12.1%	13.5%	15.8%	17.0%	15.2%	16.3%	17.4%	19.4%	19.4%	20.2%	21.0%	21.0%	20.2%	20.8%	21.7%	22.2%	21.7%	22.8%	22.80%
ROIC	37.5%	49.9%	76.6%	85.7%	1.0%	1.1%	69.2%	72.7%	76.5%	84.0%	66.9%	69.4%	71.5%	71.0%	50.1%	51.6%	54.4%	56.3%	47.7%	50.3%	50.31%
ROCE	7.6%	11.1%	12.9%	14.6%	17.7%	19.0%	20.3%	21.5%	22.6%	24.9%	26.4%	27.4%	28.3%	28.1%	25.1%	25.8%	27.7%	29.4%	27.5%	29.4%	29.37%
Gross Margin	74.7%	77.1%	77.9%	76.2%	79.7%	78.6%	75.5%	75.7%	75.5%	77.8%	76.9%	76.1%	78.1%	77.4%	76.1%	76.1%	78.2%	77.8%	75.1%	76.5%	76.50%
Operating Margin	18.8%	28.3%	26.2%	25.0%	32.8%	30.8%	28.6%	25.9%	30.8%	35.8%	29.6%	27.0%	31.4%	31.6%	29.9%	27.8%	33.3%	32.2%	31.3%	32.9%	32.93%
Net Margin	15.0%	23.6%	32.8%	20.2%	25.5%	25.6%	24.7%	22.0%	25.9%	30.7%	26.0%	23.5%	27.3%	27.6%	26.5%	24.0%	28.3%	26.3%	28.4%	26.5%	26.47%
EBITDA Margin	22.3%	31.4%	29.4%	28.5%	36.6%	34.1%	24.0%	27.1%	31.9%	36.9%	30.7%	28.3%	32.5%	32.7%	33.7%	28.8%	38.8%	36.2%	34.0%	32.9%	32.93%
FCF Margin	22.1%	25.3%	25.2%	23.9%	17.9%	17.5%	15.3%	9.3%	12.0%	7.5%	8.3%	15.9%	18.7%	24.1%	22.9%	18.6%	17.5%	17.8%	20.1%	27.9%	27.93%
OCF Margin	23.7%	27.0%	26.9%	26.1%	20.5%	20.6%	18.8%	23.5%	25.3%	20.0%	20.5%	18.8%	22.8%	33.0%	35.0%	34.6%	35.0%	31.1%	29.8%	33.5%	33.55%
ROE 3Y Avg	snapshot only																				24.28%
ROE 5Y Avg	snapshot only																				21.19%
ROA 3Y Avg	snapshot only																				20.43%
ROIC 3Y Avg	snapshot only																				51.51%
ROIC Economic	snapshot only																				23.54%
Cash ROA	snapshot only																				26.61%
Cash ROIC	snapshot only																				66.60%
CROIC	snapshot only																				55.45%
NOPAT Margin	snapshot only																				25.34%
Pretax Margin	snapshot only																				34.98%
R&D / Revenue	snapshot only																				3.83%
SGA / Revenue	snapshot only																				40.61%
SBC / Revenue	snapshot only																				2.45%

Valuation

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
P/E Ratio	73.87	63.74	57.22	50.77	32.78	27.14	25.97	34.91	39.75	33.27	34.29	30.51	29.42	33.87	35.98	33.59	36.78	42.89	55.72	52.47	49.864
P/S Ratio	9.57	10.05	12.76	11.79	8.36	7.04	6.25	8.50	9.75	8.63	8.99	8.08	7.89	8.85	9.45	8.84	9.79	11.28	14.94	14.36	13.645
P/B Ratio	5.50	6.30	7.39	7.33	5.54	4.91	4.52	6.51	7.93	7.37	8.25	7.66	7.68	8.83	7.97	7.65	8.75	10.47	13.24	13.09	11.951
P/FCF	43.32	39.79	50.74	49.24	46.70	40.30	40.78	91.32	81.39	114.47	108.02	50.76	42.17	36.77	41.18	47.47	56.06	63.55	74.53	51.41	51.409
P/OCF	40.44	37.25	47.40	45.08	40.76	34.14	33.17	36.19	38.57	43.14	43.78	43.05	34.65	26.79	27.01	25.52	27.99	36.33	50.21	42.80	42.801
EV/EBITDA	44.98	38.73	42.19	37.17	22.51	18.11	17.02	24.98	30.23	25.66	26.05	23.12	22.49	26.32	27.44	25.54	27.14	30.85	41.52	38.88	38.882
EV/Revenue	8.17	8.77	11.33	10.45	7.11	5.84	5.20	7.51	8.82	7.74	8.26	7.37	7.21	8.18	8.74	8.15	9.11	10.64	14.33	13.77	13.765
EV/EBIT	56.99	45.88	48.24	42.21	25.29	20.30	17.75	25.61	30.43	25.48	27.04	24.02	23.36	27.35	28.43	26.41	28.43	32.44	44.25	41.02	41.018
EV/FCF	37.00	34.73	45.03	43.65	39.69	33.46	33.96	80.72	73.61	102.72	99.28	46.33	38.50	33.99	38.08	43.75	52.22	59.91	71.48	49.29	49.286
Earnings Yield	1.4%	1.6%	1.7%	2.0%	3.1%	3.7%	3.9%	2.9%	2.5%	3.0%	2.9%	3.3%	3.4%	3.0%	2.8%	3.0%	2.7%	2.3%	1.8%	1.9%	1.91%
FCF Yield	2.3%	2.5%	2.0%	2.0%	2.1%	2.5%	2.5%	1.1%	1.2%	0.9%	0.9%	2.0%	2.4%	2.7%	2.4%	2.1%	1.8%	1.6%	1.3%	1.9%	1.95%
PEG Ratio	snapshot only																				2.700
Price/Tangible Book	snapshot only																				13.579
EV/OCF	snapshot only																				41.033
EV/Gross Profit	snapshot only																				17.915
Acquirers Multiple	snapshot only																				42.490
Shareholder Yield	snapshot only																				1.25%
Graham Number	snapshot only																				$17.42

Leverage & Solvency

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Current Ratio	12.96	12.96	11.18	11.18	11.18	11.18	9.06	9.06	9.06	9.06	4.65	4.65	4.65	4.65	8.84	8.84	8.84	8.84	7.98	7.98	7.977
Quick Ratio	12.16	12.16	10.54	10.54	10.54	10.54	8.43	8.43	8.43	8.43	3.87	3.87	3.87	3.87	7.62	7.62	7.62	7.62	6.84	6.84	6.835
Debt/Equity	0.04	0.04	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.000
Net Debt/Equity	-0.80	-0.80	-0.83	-0.83	-0.83	-0.83	-0.76	-0.76	-0.76	-0.76	-0.67	-0.67	-0.67	-0.67	-0.60	-0.60	-0.60	-0.60	-0.54	-0.54	-0.541
Debt/Assets	0.04	0.04	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.000
Debt/EBITDA	0.42	0.31	0.22	0.20	0.16	0.15	0.14	0.13	0.13	0.12	0.10	0.09	0.09	0.09	0.01	0.01	0.01	0.01	0.00	0.00	0.000
Net Debt/EBITDA	-7.69	-5.65	-5.35	-4.75	-3.98	-3.70	-3.42	-3.28	-3.19	-2.94	-2.29	-2.21	-2.14	-2.15	-2.23	-2.17	-2.00	-1.88	-1.77	-1.67	-1.675
Interest Coverage	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity Multiplier	1.16	1.16	1.15	1.15	1.15	1.15	1.16	1.16	1.16	1.16	1.29	1.29	1.29	1.29	1.13	1.13	1.13	1.13	1.15	1.15	1.150
Cash Ratio	snapshot only																				5.025
Defensive Interval	snapshot only																				617.1 days

Efficiency & Turnover

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Asset Turnover	0.51	0.56	0.54	0.58	0.62	0.65	0.63	0.67	0.71	0.75	0.74	0.76	0.78	0.80	0.77	0.79	0.82	0.85	0.81	0.83	0.833
Inventory Turnover	2.30	2.44	2.37	2.56	2.58	2.67	2.49	2.66	2.94	3.10	1.69	1.74	1.74	1.79	1.45	1.49	1.54	1.59	1.77	1.82	1.815
Receivables Turnover	5.95	6.49	8.61	9.25	9.85	10.36	5.79	6.13	6.50	6.84	5.14	5.31	5.45	5.59	6.43	6.60	6.82	7.07	6.92	7.12	7.124
Payables Turnover	10.55	11.20	13.56	14.63	14.78	15.28	9.31	9.95	11.00	11.62	8.43	8.68	8.66	8.92	9.00	9.24	9.53	9.84	10.49	10.76	10.756
DSO	61	56	42	39	37	35	63	60	56	53	71	69	67	65	57	55	54	52	53	51	51.2 days
DIO	159	149	154	143	141	137	147	137	124	118	216	209	210	204	251	244	237	230	206	201	201.1 days
DPO	35	33	27	25	25	24	39	37	33	31	43	42	42	41	41	39	38	37	35	34	33.9 days
Cash Conversion Cycle	186	173	169	157	154	148	171	160	147	140	243	236	234	228	267	260	252	244	224	218	218.4 days
Fixed Asset Turnover	snapshot only																				3.617
Operating Cycle	snapshot only																				252.3 days
Cash Velocity	snapshot only																				1.687
Capital Intensity	snapshot only																				1.261

Growth (YoY)

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue	-2.9%	13.0%	31.8%	39.2%	35.5%	30.7%	27.5%	25.8%	25.2%	25.2%	23.0%	19.9%	16.0%	13.2%	11.7%	11.0%	11.7%	12.9%	14.4%	14.8%	14.81%
Net Income	-14.7%	52.8%	5.8%	9.6%	1.7%	1.1%	37.6%	31.9%	20.4%	25.1%	34.0%	30.4%	26.9%	14.1%	11.9%	10.4%	10.8%	13.7%	16.9%	19.3%	19.34%
EPS	-17.9%	51.4%	5.7%	9.5%	1.7%	1.1%	37.6%	31.5%	19.6%	24.1%	32.8%	29.7%	26.6%	13.7%	11.5%	9.7%	10.2%	13.0%	16.0%	18.9%	18.93%
FCF	-6.4%	49.4%	1.0%	1.2%	9.9%	-9.6%	-22.3%	-51.1%	-16.2%	-46.0%	-33.2%	1.0%	81.3%	2.6%	2.1%	29.9%	4.2%	-16.7%	-0.0%	72.2%	72.16%
EBITDA	63.7%	3.1%	18.3%	6.8%	1.4%	86.2%	45.2%	34.5%	15.7%	17.0%	27.6%	27.1%	27.4%	16.6%	12.1%	11.1%	17.1%	25.3%	24.0%	27.4%	27.39%
Op. Income	97.1%	7.8%	14.0%	38.2%	1.7%	96.8%	59.2%	49.0%	29.2%	32.1%	28.2%	25.5%	23.5%	11.5%	9.6%	9.0%	11.0%	16.5%	19.0%	23.4%	23.42%
OCF Growth	snapshot only																				11.18%
Asset Growth	snapshot only																				10.63%
Equity Growth	snapshot only																				8.98%
Debt Growth	snapshot only																				-1.00%
Shares Change	snapshot only																				0.35%
Dividend Growth	snapshot only																				96.29%

Growth (CAGR)

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue 3Y	9.5%	10.1%	11.2%	12.2%	12.5%	11.8%	11.4%	13.4%	18.1%	22.7%	27.4%	28.0%	25.3%	22.8%	20.5%	18.7%	17.5%	17.0%	16.3%	15.2%	15.18%
Revenue 5Y	-0.3%	1.7%	5.2%	9.4%	14.4%	17.6%	18.2%	17.7%	17.4%	16.9%	16.6%	16.3%	15.6%	14.7%	13.7%	14.2%	16.4%	18.8%	21.5%	21.7%	21.74%
EPS 3Y	19.3%	7.1%	12.7%	11.3%	13.6%	16.2%	9.2%	11.9%	37.6%	59.1%	1.3%	1.6%	59.0%	44.6%	26.8%	23.3%	18.6%	16.8%	19.8%	19.2%	19.18%
EPS 5Y	-13.1%	-7.6%	3.7%	13.5%	32.0%	52.5%	88.8%	52.2%	40.1%	26.7%	21.2%	18.7%	17.3%	17.3%	14.0%	14.8%	29.4%	39.0%	74.0%	87.7%	87.67%
Net Income 3Y	21.1%	8.3%	13.9%	12.6%	14.9%	17.2%	10.0%	12.9%	40.0%	60.2%	1.3%	1.6%	59.8%	45.3%	27.3%	23.8%	19.2%	17.5%	20.6%	19.8%	19.75%
Net Income 5Y	-12.3%	-6.5%	5.3%	17.3%	34.0%	55.0%	91.4%	54.3%	41.7%	27.8%	22.2%	19.7%	18.3%	18.1%	14.8%	15.7%	31.0%	39.8%	75.0%	88.7%	88.71%
EBITDA 3Y	6.7%	10.9%	16.4%	18.5%	22.3%	18.7%	17.0%	22.4%	64.6%	1.1%	2.3%	1.4%	51.5%	36.5%	27.6%	23.8%	20.0%	19.6%	21.1%	21.6%	21.62%
EBITDA 5Y	-14.0%	-7.6%	0.2%	11.2%	28.3%	50.7%	54.4%	37.0%	27.1%	24.3%	24.0%	23.3%	22.0%	17.9%	18.1%	21.0%	46.1%	67.4%	1.2%	80.2%	80.16%
Gross Profit 3Y	9.0%	10.1%	11.3%	12.4%	12.8%	12.1%	11.6%	13.6%	18.7%	23.8%	28.6%	28.9%	26.4%	23.4%	20.7%	18.9%	17.1%	16.4%	15.9%	15.0%	14.97%
Gross Profit 5Y	-1.9%	0.2%	4.0%	8.5%	14.3%	18.1%	18.7%	17.9%	17.3%	16.9%	16.6%	16.5%	15.7%	14.5%	13.7%	14.2%	16.9%	19.7%	22.2%	22.4%	22.36%
Op. Income 3Y	8.5%	12.2%	17.8%	20.0%	23.5%	20.9%	21.8%	28.1%	89.1%	1.8%	—	3.2%	61.9%	42.6%	30.8%	26.8%	21.0%	19.7%	18.7%	19.1%	19.07%
Op. Income 5Y	-17.7%	-10.4%	-2.1%	9.1%	26.3%	51.9%	64.8%	44.7%	34.4%	29.7%	27.3%	26.4%	24.6%	21.1%	20.5%	23.5%	56.1%	97.3%	—	1.5%	1.50%
FCF 3Y	9.7%	25.4%	13.9%	20.5%	6.4%	-2.5%	-5.7%	-19.7%	-4.8%	-10.0%	1.8%	29.3%	18.6%	20.8%	16.9%	9.2%	16.5%	17.6%	27.2%	66.1%	66.14%
FCF 5Y	0.8%	2.7%	5.9%	14.3%	12.3%	22.6%	25.8%	2.9%	4.0%	-0.8%	-5.2%	11.9%	12.8%	12.6%	11.5%	6.7%	10.3%	17.0%	26.5%	37.1%	37.05%
OCF 3Y	9.2%	25.7%	15.1%	22.1%	9.8%	1.8%	-0.6%	7.2%	18.6%	20.1%	32.3%	31.7%	23.8%	31.4%	31.5%	30.4%	40.4%	34.1%	35.4%	29.7%	29.71%
OCF 5Y	-0.8%	1.3%	3.7%	11.6%	11.3%	19.6%	24.1%	20.7%	18.7%	19.2%	12.8%	14.5%	16.4%	19.1%	20.2%	19.3%	24.5%	28.0%	33.8%	39.1%	39.07%
Assets 3Y	22.1%	22.1%	19.6%	19.6%	19.6%	19.6%	8.6%	8.6%	8.6%	8.6%	9.0%	9.0%	9.0%	9.0%	5.9%	5.9%	5.9%	5.9%	8.4%	8.4%	8.35%
Assets 5Y	15.1%	15.1%	17.4%	17.4%	17.4%	17.4%	17.0%	17.0%	17.0%	17.0%	13.7%	13.7%	13.7%	13.7%	8.1%	8.1%	8.1%	8.1%	8.9%	8.9%	8.89%
Equity 3Y	23.1%	23.1%	19.8%	19.8%	19.8%	19.8%	9.9%	9.9%	9.9%	9.9%	5.2%	5.2%	5.2%	5.2%	6.4%	6.4%	6.4%	6.4%	8.7%	8.7%	8.70%
Book Value 3Y	21.3%	21.7%	18.5%	18.5%	18.5%	18.8%	9.1%	9.0%	8.0%	9.2%	4.6%	4.5%	4.6%	4.7%	5.9%	5.9%	5.8%	5.7%	8.0%	8.2%	8.18%
Dividend 3Y	—	—	—	—	—	—	—	0.9%	-0.0%	1.1%	1.1%	-16.0%	-9.8%	-4.2%	0.7%	-0.9%	-6.8%	-11.2%	2.5%	24.6%	24.61%

Growth Quality

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue Stability	0.04	0.15	0.35	0.62	0.86	0.88	0.81	0.81	0.87	0.87	0.85	0.86	0.88	0.89	0.90	0.94	0.98	1.00	1.00	0.99	0.994
Earnings Stability	0.03	0.00	0.05	0.15	0.54	0.59	0.46	0.42	0.67	0.65	0.51	0.49	0.73	0.77	0.68	0.69	0.94	0.96	0.95	0.94	0.936
Margin Stability	0.97	0.96	0.97	0.98	0.98	0.98	0.98	0.99	0.99	0.98	0.98	0.99	0.99	0.99	1.00	1.00	0.99	0.98	0.98	0.99	0.988
Rev. Growth Consistency	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.94	0.50	0.50	0.50	0.50	0.50	0.85	0.87	0.92	0.90	0.86	0.88	0.89	0.94	0.95	0.96	0.96	0.95	0.93	0.92	0.923
Earnings Smoothness	0.84	0.58	0.00	0.00	0.09	0.27	0.68	0.73	0.81	0.78	0.71	0.74	0.76	0.87	0.89	0.90	0.90	0.87	0.84	0.82	0.824
ROE Trend	-0.07	-0.03	0.03	0.05	0.08	0.10	0.10	0.11	0.08	0.08	0.09	0.09	0.08	0.06	0.01	0.01	0.01	0.00	0.01	0.01	0.010
Gross Margin Trend	-0.01	0.00	0.01	0.01	0.02	0.03	0.02	0.02	-0.00	-0.01	-0.01	-0.00	0.00	-0.00	-0.00	0.00	0.00	0.00	0.00	0.00	0.001
FCF Margin Trend	0.00	0.03	0.04	0.03	-0.05	-0.05	-0.05	-0.10	-0.08	-0.14	-0.12	-0.01	0.04	0.12	0.11	0.06	0.02	0.02	0.04	0.11	0.107
Sustainable Growth Rate	7.8%	10.4%	14.0%	-3.2%	-0.5%	0.7%	0.4%	0.7%	2.0%	4.3%	5.5%	13.7%	12.1%	9.4%	7.0%	15.1%	15.8%	16.2%	8.2%	9.0%	9.01%
Internal Growth Rate	7.1%	9.7%	13.8%	—	—	0.6%	0.3%	0.6%	1.8%	3.8%	4.7%	12.6%	11.0%	8.4%	6.2%	14.3%	15.2%	15.5%	7.7%	8.6%	8.57%

Cash Flow Quality

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
OCF/Net Income	1.83	1.71	1.21	1.13	0.80	0.79	0.78	0.96	1.03	0.77	0.78	0.71	0.85	1.26	1.33	1.32	1.31	1.18	1.11	1.23	1.226
FCF/OCF	0.93	0.94	0.93	0.92	0.87	0.85	0.81	0.40	0.47	0.38	0.41	0.85	0.82	0.73	0.66	0.54	0.50	0.57	0.67	0.83	0.833
FCF/Net Income	snapshot only																				1.021
OCF/EBITDA	snapshot only																				0.948
CapEx/Revenue	1.6%	1.7%	1.8%	2.2%	2.6%	3.1%	3.5%	14.2%	13.3%	12.5%	12.2%	2.8%	4.1%	9.0%	12.0%	16.0%	17.5%	13.3%	9.7%	5.6%	5.62%
CapEx/Depreciation	snapshot only																				3.048
Accruals Ratio	-0.05	-0.06	-0.03	-0.02	0.03	0.03	0.03	0.01	-0.01	0.04	0.04	0.06	0.03	-0.06	-0.07	-0.07	-0.07	-0.04	-0.02	-0.05	-0.052
Sloan Accruals	snapshot only																				0.026
Cash Flow Adequacy	snapshot only																				1.427
Earnings Quality Score	snapshot only																				0.750

Dividends & Buybacks

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Dividend Yield	0.0%	0.0%	0.0%	2.4%	3.1%	3.5%	3.8%	2.8%	2.3%	2.4%	2.2%	1.5%	1.8%	1.9%	2.0%	1.2%	1.1%	0.9%	1.2%	1.2%	1.35%
Dividend/Share	$0.00	$0.00	$0.00	$0.99	$0.99	$0.99	$0.99	$1.04	$1.04	$1.04	$1.04	$0.63	$0.77	$0.92	$1.07	$0.61	$0.63	$0.65	$1.17	$1.20	$1.24
Payout Ratio	0.0%	0.0%	0.0%	1.2%	1.0%	96.3%	97.9%	96.2%	90.0%	81.0%	76.9%	44.5%	53.0%	63.2%	71.1%	39.7%	39.3%	39.6%	66.9%	65.4%	65.37%
FCF Payout Ratio	0.0%	0.0%	0.0%	1.2%	1.5%	1.4%	1.5%	2.5%	1.8%	2.8%	2.4%	74.0%	75.9%	68.6%	81.4%	56.2%	60.0%	58.7%	89.5%	64.0%	64.05%
Total Payout Ratio	0.0%	0.0%	0.0%	1.2%	1.0%	96.3%	97.9%	96.2%	90.0%	81.0%	76.9%	44.5%	53.0%	63.2%	71.1%	39.7%	39.3%	39.6%	66.9%	65.4%	65.37%
Div. Increase Streak	—	—	—	0	0	0	0	1	1	1	1	0	0	0	1	0	0	0	1	0	0
Chowder Number	—	—	—	—	—	—	—	0.08	0.08	0.08	0.08	-0.38	-0.24	-0.09	0.05	-0.00	-0.17	-0.28	0.11	0.98	0.975
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	-0.0%	-0.0%	-0.0%	-0.0%	0.0%	0.0%	0.00%
Total Shareholder Return	0.0%	0.0%	0.0%	2.4%	3.1%	3.5%	3.8%	2.8%	2.3%	2.4%	2.2%	1.5%	1.8%	1.9%	2.0%	1.2%	1.1%	0.9%	1.2%	1.2%	1.25%

DuPont Factors

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Tax Burden (NI/EBT)	0.90	0.82	0.95	0.94	0.91	0.89	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.78	0.782
Interest Burden (EBT/EBIT)	1.01	1.00	1.00	1.00	1.00	1.01	1.04	1.05	1.07	1.09	1.08	1.09	1.10	1.11	1.08	1.08	1.05	1.02	1.04	1.04	1.042
EBIT Margin	0.14	0.19	0.23	0.25	0.28	0.29	0.29	0.29	0.29	0.30	0.31	0.31	0.31	0.30	0.31	0.31	0.32	0.33	0.32	0.34	0.336
Asset Turnover	0.51	0.56	0.54	0.58	0.62	0.65	0.63	0.67	0.71	0.75	0.74	0.76	0.78	0.80	0.77	0.79	0.82	0.85	0.81	0.83	0.833
Equity Multiplier	1.18	1.18	1.15	1.15	1.15	1.15	1.15	1.15	1.15	1.15	1.22	1.22	1.22	1.22	1.20	1.20	1.20	1.20	1.14	1.14	1.141

Per Share

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
EPS (Diluted TTM)	$0.36	$0.48	$0.74	$0.82	$0.97	$1.03	$1.02	$1.08	$1.15	$1.28	$1.35	$1.41	$1.46	$1.46	$1.50	$1.54	$1.61	$1.65	$1.75	$1.83	$1.83
Book Value/Share	$4.89	$4.87	$5.71	$5.70	$5.71	$5.71	$5.83	$5.81	$5.79	$5.78	$5.61	$5.60	$5.60	$5.59	$6.79	$6.77	$6.77	$6.75	$7.35	$7.35	$7.71
Tangible Book/Share	$4.81	$4.79	$5.62	$5.61	$5.62	$5.63	$5.67	$5.64	$5.63	$5.62	$5.41	$5.40	$5.40	$5.39	$6.55	$6.53	$6.53	$6.51	$7.09	$7.09	$7.09
Revenue/Share	$2.81	$3.05	$3.31	$3.55	$3.78	$3.98	$4.22	$4.45	$4.71	$4.94	$5.15	$5.31	$5.45	$5.58	$5.73	$5.86	$6.05	$6.26	$6.51	$6.70	$6.75
FCF/Share	$0.62	$0.77	$0.83	$0.85	$0.68	$0.70	$0.65	$0.41	$0.56	$0.37	$0.43	$0.84	$1.02	$1.34	$1.31	$1.09	$1.06	$1.11	$1.31	$1.87	$1.89
OCF/Share	$0.66	$0.82	$0.89	$0.93	$0.78	$0.82	$0.80	$1.05	$1.19	$0.99	$1.06	$1.00	$1.24	$1.84	$2.00	$2.03	$2.12	$1.94	$1.94	$2.25	$2.26
Cash/Share	$4.14	$4.12	$4.95	$4.94	$4.95	$4.95	$4.59	$4.57	$4.56	$4.55	$3.91	$3.90	$3.90	$3.89	$4.09	$4.07	$4.07	$4.06	$3.97	$3.98	$4.41
EBITDA/Share	$0.51	$0.69	$0.89	$1.00	$1.19	$1.29	$1.29	$1.34	$1.37	$1.49	$1.63	$1.69	$1.74	$1.73	$1.82	$1.87	$2.03	$2.16	$2.25	$2.37	$2.37
Debt/Share	$0.22	$0.22	$0.20	$0.20	$0.20	$0.20	$0.17	$0.17	$0.17	$0.17	$0.16	$0.16	$0.16	$0.16	$0.01	$0.01	$0.01	$0.01	$0.00	$0.00	$0.00
Net Debt/Share	$-3.92	$-3.91	$-4.75	$-4.74	$-4.75	$-4.75	$-4.42	$-4.39	$-4.38	$-4.38	$-3.75	$-3.74	$-3.74	$-3.73	$-4.07	$-4.06	$-4.06	$-4.05	$-3.97	$-3.98	$-3.98

Academic Models

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	55.784
Altman Z-Prime	snapshot only																				99.875
Piotroski F-Score	6	8	7	6	6	6	6	5	6	5	6	6	6	6	7	8	8	8	5	6	6
Beneish M-Score	-2.82	-2.92	-2.46	-2.45	-2.27	-2.28	-0.84	-0.99	-1.02	-0.79	-2.20	-2.12	-2.28	-2.65	-2.79	-2.79	-2.78	-2.66	-2.47	-2.59	-2.591
Ohlson O-Score	snapshot only																				-13.292
ROIC (Greenblatt)	snapshot only																				30.52%
Net-Net WC	snapshot only																				$5.21
EVA	snapshot only																				$17518673.39

Credit

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Credit Rating	snapshot only																				AA
Credit Score	92.75	92.38	92.77	92.66	93.43	93.36	94.22	93.05	93.62	93.43	93.35	93.05	93.40	93.06	93.28	93.17	93.52	93.02	89.00	89.00	89.000
Credit Grade	snapshot only																				3
Credit Trend	snapshot only																				-4.173
Implied Spread (bps)	snapshot only																				80.000
Industry Credit Rank	snapshot only																				84
Sector Credit Rank	snapshot only																				87

IRMD NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet